v3.26.1
Note 16 - Geographic and Segment Information
6 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Segment Reporting [Text Block]

Note 16. Geographic and Segment Information

 

Geographic Information

 

All our long-lived assets, composed of property and equipment, net by location, were held in the U.S. All our revenue from external customers was generated in the U.S.

 

Segment Information

 

Our Products segment measures of profit and loss is consolidated loss from operations, and its measure of total assets is consolidated total assets. Our CODM uses loss from operations predominantly in the annual budget and forecasting process to monitor variances in budget versus actual results along with consolidated total assets to determine resource allocation. Segment revenue from external customers, significant segment non-cash items, and other significant segment expense categories included within the measure of profit and loss and provided to our CODM were all based on their consolidated amounts. During the three and six months ended June 30, 2026 and 2025, these items were as follows:

 

  

Three Months Ended June 30,

  

Six Months Ended June 30,

 

(in thousands)

 

2026

  

2025

  

2026

  

2025

 

Segment revenue from external customers

 $90  $27  $105  $108 

Segment operating expenses:

                

Cost of revenue

  36      36   20 

Research and development:

                

CNM-Au8:

                

Amyotrophic lateral sclerosis

  712   1,468   1,536   2,811 

Multiple sclerosis

  37   164   107   189 

Regulatory activities

  371   130   567   260 

General/preclinical/nonclinical

  101   19   121   82 

Facilities

  393   386   784   805 

Depreciation

  336   337   674   675 

Manufacturing

  522   187   155   270 

Research

  1   2   10   7 

Equipment

  24   14   84   28 

Maintenance

  32   32   49   64 

Information technology

  76   54   143   119 

Personnel

  2,188   2,100   4,211   4,260 

Stock-based compensation

  526   600   1,240   1,546 

Grant revenue as a reduction of research and development expense

  (1,864)  (2,058)  (5,914)  (6,225)

Other segment items ‒ Research and development(1)

  16   79   33   104 

General and administrative:

                

Insurance

  177   181   328   362 

Legal

  144   175   195   323 

Finance and accounting

  155   220   488   530 

Public and investor relations

  109   119   202   230 

Facilities

  30   31   63   61 

Depreciation

  17   29   34   95 

Information technology

  40   47   62   96 

Personnel

  779   788   1,417   1,620 

Stock-based compensation

  514   767   1,112   1,768 

Grant revenue as a reduction of general and administrative expense

  (93)  (65)  (329)  (228)

Other segment items ‒ General and administrative(2)

  58   85   105   176 

Segment loss from operations

  (5,347)  (5,864)  (7,408)  (9,940)
                 

Reconciliation of segment loss from operations:

                

Adjustments and reconciling items

            

Consolidated loss from operations

 $(5,347) $(5,864) $(7,408) $(9,940)

 

(1)

Includes expenses for travel, meals, dues, subscriptions, continuing education, and other miscellaneous expenses.

 

 (2)

Includes expenses for travel, meals, dues, subscriptions, continuing education, lobbying, banking fees, postage, and other office and miscellaneous expenses.

 

Our revenue during the three and six months ended June 30, 2026 and 2025 was predominantly with a single customer, 4Life, through our Amended 4Life Agreements (see Note 15). A reconciliation of the total of the Products segment loss from operations to consolidated net loss before income taxes for the three and six months ended June 30, 2026 and 2025 was as follows:

 

  

Three Months Ended June 30,

  

Six Months Ended June 30,

 

(in thousands)

 

2026

  

2025

  

2026

  

2025

 

Segment loss from operations

 $(5,347) $(5,864) $(7,408) $(9,940)

Total other income (expense), net(1)

  (8,077)  (1,555)  (14,107)  1,770 

Net loss before income taxes

 $(13,424) $(7,419) $(21,515) $(8,170)

 

(1)

Represents consolidated total other income (expense), net, as reported on the consolidated statements of operations and comprehensive loss.

 

Products segment assets exclude corporate assets, such as cash, restricted cash, and corporate facilities. Total assets as of June 30, 2026 and  December 31, 2025 were as follows:

 

  

June 30,

  

December 31,

 

(in thousands)

 

2026

  

2025

 

Total assets:

        

Products

 $13,290  $12,828 

Corporate

  9,751   5,303 

Consolidated

 $23,041  $18,131 

 

Additions to long-lived assets during the six months ended June 30, 2026 were insignificant. We had no additions during the six months ended June 30, 2025.